arrow
S

Santiago Barrio

hospital universitario 12 de octubre
H指数:21
被引数:2,213

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploratory Study to Evaluate the Impact of Interim PET/CT Assessment in First-Line Follicular Lymphoma

探索性研究:评估首次滤泡性淋巴瘤治疗中中期PET/CT评估的影响

CANCERS
IF4.4
2025-03-210
OA
A large-scale database of T-cell receptor beta sequences and binding associations from natural and synthetic exposure to SARS-CoV-2
2025-02-171
OAAI
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels

在个人和人群水平上对SARS-CoV-2感染的T细胞反应的大小和动态

2025-01-070
OAAI
Epigenetic Modifications As a Mechanism of Resistance to BCMA-Directed Immunotherapies in Multiple Myeloma: Insights from Multi-Omic Profiling

表观遗传修饰作为多发性骨髓瘤对BCMA靶向免疫疗法产生耐药性的机制:多组学分析见解

BLOOD
IF23.1
2024-11-051
PRE
Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myeloma

克隆竞争测定鉴定多发性骨髓瘤的癌症进展和耐药性的适应性特征

2024-07-111
OAAI
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA (vol 12, 13057, 2022)
2024-03-280
OAAI
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
2024-01-100
OAAI
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma
2023-12-210
OAAI
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients (vol 14, 1188818, 2023)
2023-08-160
OAAI
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
2023-06-055
OAAI
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT
LEUKEMIA
IF13.4
2023-01-0318
OA
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma
2022-10-257
OA
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA
2022-07-2911
OAAI
Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma

根据可测量的残留疾病做出临床决策可改善多发性骨髓瘤的结局

2021-08-1723
OAAI
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis
LEUKEMIA
IF13.4
2020-03-1911
OAAI
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients
2020-02-0618
OAAI